Skip to main content
HROW
NASDAQ Life Sciences

Harrow Posts 25c Q3 EPS, Swinging to Profit From Prior Loss

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$27.44
Mkt Cap
$1.029B
52W Low
$25.76
52W High
$54.85
52W Position info
6.5% above low
Off High info
50% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

HROW is trading near its 52-week low of $25.76 (6.5% above the low).

Summary

Harrow reported third-quarter EPS of 25 cents, a sharp turn from the $17.3M net loss it posted in Q2, on revenue of $99.3M that slightly beat estimates on branded product growth. That Q2 loss came on revenue of $70.7M, up 60% sequentially on VEVYE and other branded products, so a positive EPS print implies the top line and cost base both moved the right way. Third-quarter gross margin was 75%. The quarter also includes the first contribution from TYRVAYA, which Harrow closed on October 5 under revised terms with Viatris retaining Japan rights. The company cut its full-year adjusted EBITDA outlook, which it had set above $40M.

At the time of this announcement, HROW was trading at $27.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1B. The 52-week trading range was $25.76 to $54.85. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

HROW - Latest Insights

HROW
Nov 09, 2026, 5:12 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $31.90
Real-time Price: $31.95 info
Change: +$0.0499 (+0.16%) info
Market Cap: $1.03B info
HROW
Nov 09, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $31.14
Real-time Price: $31.95 info
Change: +$0.8069 (+3%) info
Market Cap: $1.03B info
HROW
Oct 05, 2026, 7:32 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.90
Real-time Price: $31.95 info
Change: +$1.05 (+3%) info
Market Cap: $1.03B info
HROW
Aug 21, 2026, 12:09 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $41.61
Real-time Price: $31.95 info
Change: -$9.66 (-23%) info
Market Cap: $1.03B info
HROW
Aug 10, 2026, 4:28 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $40.05
Real-time Price: $31.95 info
Change: -$8.10 (-20%) info
Market Cap: $1.03B info